1. Home
  2. EBON vs AEON Comparison

EBON vs AEON Comparison

Compare EBON & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ebang International Holdings Inc.

EBON

Ebang International Holdings Inc.

HOLD

Current Price

$1.65

Market Cap

16.0M

Sector

Technology

ML Signal

HOLD

Logo AEON Biopharma Inc.

AEON

AEON Biopharma Inc.

HOLD

Current Price

$0.14

Market Cap

13.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EBON
AEON
Founded
2010
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.0M
13.0M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
EBON
AEON
Price
$1.65
$0.14
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $1.82
AVG Volume (30 Days)
8.5K
★ 613.5K
Earning Date
08-14-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.35
$0.13
52 Week High
$3.89
$1.45

Technical Indicators

Market Signals
Indicator
EBON
AEON
Relative Strength Index (RSI) 45.18 30.37
Support Level $1.35 $0.13
Resistance Level $2.34 $0.33
Average True Range (ATR) 0.17 0.03
MACD -0.01 -0.01
Stochastic Oscillator 48.57 8.69

Price Performance

Historical Comparison
EBON
AEON

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is engaged in blockchain technology and fintech, with activities also extending to the solar industry, supported by its application-specific integrated circuit (ASIC) chip designs. The Company's business mainly includes the sale of bitcoin mining machines and related accessories, telecommunication products, solar and battery storage products, cryptocurrency exchange services, cross-border payment and foreign exchange services, SaaS data visualization and analytics solutions, and rental services. It generates the majority of its revenue from cross-border payment and foreign exchange services, with its operations mainly in mainland China and Australia, which contribute the maximum revenue.

About AEON AEON Biopharma Inc.

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

Share on Social Networks: